Tag / REMS
-
Risk Evaluation and Mitigation Strategy (REMS) – Impact on Pain Treatment
In July 2012, the US Food and Drug Administration released a risk evaluation and mitigation strategy (REMS) for extended release pain medications.
Loading posts...
